AUCTORES
Globalize your Research
Case Report | DOI: https://doi.org/10.31579/2639-4162/002
*Corresponding Author: Ashwin Malhotra, Department of Medicine, Stony Brook University Hospital, New York, USA, Tel: 516-749-4678,
Citation: Ashwin Malhotra, Ramsey Al-Khalil, Imran Baig, The Underrecognized Cardiac Manifestation of Hypereosinophilic Syndrome, j General Medicine and Clinical Practice, Doi: 10.31579/2639-4162/002
Copyright: © 2018 Ashwin Malhotra. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 20 July 2018 | Accepted: 01 August 2018 | Published: 06 August 2018
Keywords: Keywords
Abstract
Hypereosinophilic syndrome (HES) is a rare systemic disease in which cardiac manifestations are the leading cause of morbidity and mortality. HES involvement of the heart can often clinically mimic acute coronary syndrome (ACS) with the patient undergoing repeat cardiac catheterizations when no conclusive diagnosis is arrived at, and no effective treatment is suggested to alleviate recurrent symptoms of chest discomfort. Here we present an elusive case of eosinophilic myocarditis (EM) and advocate that a detailed review of history as well as obtaining all medical records be done to avoid unnecessary and repeated invasive investigations in order to provide safe, cost effective, and efficient care for our patients.
A 69-year-old man with history of hypertension, anxiety, benign prostatic hyperplasia, ulcerative colitis (UC) diagnosed 30 years ago, and hyperesosinophilic syndrome (HES) restricted to the colon presented to the emergency room with worsening mid-sternal chest pressure. The chest pressure initially started several hours ago when patient was getting out of bed, however in the thirty minutes prior to presentation it turned to chest pain with associated with shortness of breath, lightheadedness, warmth, and numbness of the left arm. On admission, symptoms did not worsen with exertion or positioning, and recent history was negative for fever, chills, flushing, rash, abdominal pain, or diarrhea. Initial physical examination was unremarkable, however laboratory studies were significant for elevated troponin I (0.15, 0.14, and 0.14), WBC 16.7, Absolute Eosinophil Count (AEC) 7800, and ESR 100. EKG revealed no ST or T wave abnormalities concerning for ongoing ischemia. Renal function and liver function were noted to be within normal limits, along with serum electrolytes, and patient was not found to be anemic.
The patient was initially triaged and planned to be managed as a case of Non-ST-Elevation-MI and subsequently was being evaluated for initiation of a Heparin drip and coronary angiogram. Patient was given aspirin 325 mg, supplemental oxygen, intravenous fluids, beta-blocker, a diuretic, and a statin in addition to patient’s home medications, which notably included aspirin 81 mg, mesalamine, montelukast, prednisone 10 mg daily, ranitidine, and tamsulosin. The patient was admitted to General Medicine Service, and Cardiology Service was consulted. On further history patient revealed he had two similar episodes of chest pain in the past where he was evaluated in two different emergency departments. In both occurrences, the patient was admitted for further cardiac work-up secondary to elevated troponins. Outside records were obtained and it was discovered our patient recently underwent cardiac catheterization which revealed non-obstructive coronary artery disease.
Next, we noted the seemingly unrelated diagnosis of hypereosinophilic involvement of the colon was made in 2007 after patient continued to have refractory symptoms of diarrhea despite adequate treatment for UC. Biopsies of the cecum, ascending, transverse, descending, and sigmoid colon all revealed marked eosinophilic and plasmacytic infiltration. Rectal biopsy showed mild eosinophilic and plasmacytic infiltration. No ova or parasitic infestation was noted and serum AEC was mildly elevated at 1000. The patient did not manifest any other symptoms aside from the diarrhea and therefore a diagnosis of hypereosinophilic involvement of the colon was established at that time.
Patient’s diarrhea resolved with the initiation of Prednisone 20 mg daily. The prednisone dose was eventually tapered down to a maintenance dose of 10 mg and a leukotriene inhibitor, montelukast was added to the regimen which allowed patient to remain symptom free. A bone marrow biopsy demonstrated increased eosinophils without mutations in JAK2 V617F, MPL, or CALR, which are associated with classic myeloproliferative neoplasms.
With our additional history, an unremarkable physical exam, and complete resolution of chest pain in the emergency department, our suspicion for an NSTEMI event decreased and the patient was not started on a Heparin drip. An investigation to uncover the underlying disease process was initiated. Given patient’s clinical presentation despite a normal cardiac catheterization, his prior hypereosinophilic infiltration of the colon, along with supporting laboratory abnormalities, a diagnosis of hypereosinophilic myocarditis was entertained as the most likely etiology for our patient’s clinical presentation. Hematology Service was consulted and prednisone was increased to 50 mg (1 mg/kg in our patient who weighs 54 kg).
After initiation of the high dose steroids, our patient remained asymptomatic for the subsequent 48 hours. Moreover, he remained clinically and hemodynamically stable and was found to be stable for discharge with outpatient follow up. All recent records, including cardiac catheterization and echocardiography, were reviewed and patient was advised on risk factor modification and initiated on ibuprofen 800mg three times a day and colchicine 0.6mg once daily and prednisone 50 mg once daily by mouth until follow up appointment. All home medications were continued after discharge including statin, and low dose Aspirin. An outpatient appointment was scheduled for 2 weeks to trend labs, specifically cardiac enzymes (troponins, CK-MB), and AEC, as well as to evaluate for areas of inflammation and eosinophilic infiltrates via a cardiac MRI study. On initial follow up, our patient continues to do well without recurrence of chest pain or pressure. A test for the PDGFRA mutation was also arranged in order to determine if imagine could confer a further therapeutic benefit in our patient. Unfortunately, our patient was lost to subsequent follow up and did not complete a cardiac MRI to help confirm the diagnosis.
A presentation of any patient with chest pain in the emergency department must be approached with a sense of urgency, where the work-up and management are often started concomitantly. In patients with recurrent and refractory symptoms, we recommend that after initial stabilization, the differential diagnosis should be explored beyond the more commonly established diagnosis of cardiac ischemia. Eosinophilic myocarditis (EM), for example, is such a disease state and often presents as emergent chest pain under the guise of an NSTEMI. However, management and outcomes vary tremendously. The Condition
Hypereosinophilic syndrome (HES) is a rare disease with limited epidemiological data [1]. Previously defined as a collection of heterogeneous disorders characterized by eosinophilia in the periphery, in tissue, or both in the setting of various clinical manifestations, many subtypes of HES have been elucidated [2]. These include clonal hypereosinophilia, chronic eosinophilic leukemia, lymphocytic HES, myeloproliferative HES, organ-restricted HES, and idiopathic HES.
Subsequently, the definition of HES has been refined to include an Absolute Eosinophil Count (AEC) greater than 1500 eosinophils/mm3 for greater than six months. The leading cause of morbidity and mortality in patients with HES continues to be cardiac disease, specifically myocarditis [3]. Albeit cardiac diseases have been reported in up to 50% of HES cases, eosinophilic myocarditis (EM) is largely underrecognized and patients are often not only underdiagnosed, but also not fully treated. Over time, repeated uninhibited myocyte infiltration may lead to conduction system damage which can then progress to fulminant heart failure [4]. Treatment of HES depends on the presence or absence of the FIP1L1-PDGFRA mutation, which leads to constitutively active tyrosine kinase. A near complete cure rate with imatinib therapy has been reported for patients with the mutation; whereas patients without the mutation are managed with glucocorticoids primarily, and hydroxyurea/IFN-alpha reserved for refractory cases [1,5].
In healthy individuals, eosinophils are absent from most tissues, except for lymphatic tissue (thymus, spleen, lymph nodes), bone marrow, uterus and gastrointestinal tract [6]. Broadly, hypereosinophilic syndrome can be characterized as reactive, lymphocytic, and
myeloproliferative. While the pathogenesis of eosinophilia and end organ damage are similar in all HES subtypes, treatment varies depending on the specific etiology.
The pathogenesis of HES is thought to involve eosinophil expansion, recruitment, degranulation, and delayed-type hypersensitivity reactions. CD34+ pluripotent myeloid progenitors are stimulated by IL-3 and GM-CSF with terminal differentiation of eosinophils driven by IL-5 [7]. Expansion of circulating eosinophils has been attributed to (1) IL-3, IL-5, or GM-CSF-induced proliferation by activated T-cells or (2) cytogenetic abnormalities leading to constitutional signal transduction such as that seen in the FLIP1-PDGFR fusion gene [8]. Once in circulation, eosinophils are trafficked to various sites throughout the body. Common mediators such as VLA4 and PSGL-1 have been implicated in eosinophil margination and adhesion, although chemokine mediators of organ-specific homing remains poorly understood [9]. Upon tissue extraversion, eosinophils are aberrantly activated and degranulate cytotoxic compounds which mediate tissue damage. The mechanisms causing eosinophil degranulation is largely unknown with implicated mediators consisting of IL-5, IFN-g and sIgA to name a few [10]. Cytotoxic proteins released during degranulation include major basic protein, ECP, EPO, and EDN; all of which promote cellular damage and fibrosis of the involved organs [11]. Delayed-type hypersensitivity reactions involve Th1 recruitment, IL-5 release, and subsequent eosinophil differentiation from progenitor cells.
HES can affect any organ system causing clinical symptoms that range from a cough to peripheral neuropathy. Presenting symptoms in one case series included fatigue, cough, breathlessness, muscle pain/angioedema, rash/fever and retinal lesions [12]. With disease progression, HES typically involves the cardiovascular, pulmonary, gastrointestinal, and peripheral nervous systems. Greater than 50% of patients with HES have cardiac involvement in the form of eosinophilic myocarditis, which may include tissue necrosis, endomyocardial thrombosis, and even myocardial fibrosis [13]. During the necrotic stage, eosinophilic degranulation can cause micro-abscess formation in the myocardium with little functional effect. After sufficient damage to the endocardium, thrombi tend to form along the ventricles and atrioventricular valve leaflets leading to cardiac functional abnormalities and increased risk of cardio-embolic strokes in advanced disease. Furthermore, with untreated cardiac disease, progressive myocardial scarring will develop which can lead to entrapped chordae tendinae causing mitral and tricuspid regurgitation in addition to restrictive cardiomyopathy [12].
Serum studies are critical to the diagnosis of HES: an absolute eosinophil count ≥ 1.5 x 109/L measured on two separate occasions separated by at least 4 weeks or eosinophilia ≥ 1.5 x 109/L with eosinophil mediated end organ damage and the absence of a more likely diagnosis [6]. The diagnosis and treatment is also largely dependent on ruling out secondary causes of eosinophilia and identifying which HES variant a patient has. The approach to patients with eosinophilia starts with eliminating myeloid neoplasms such as chronic myeloid leukemia, myeloproliferative syndromes and myelodysplastic syndromes as possible diagnoses [1]. If myeloproliferative disease is suspected a bone marrow biopsy, cytology, histology and molecular analysis should be performed. Once hematologic malignancy is excluded from the differential, diagnostic testing is guided by degree of eosinophilia and clinical manifestations. In 2009, the Japanese Circulation Society Task Force Committee on Acute and Chronic Myocarditis created diagnostic criteria for patients with EM. This includes peripheral eosinophilia >500/mm3, cardiac symptoms, elevated cardiac enzymes, ECG changes, and transient left ventricular wall thickening and wall motion abnormality on echocardiography [14]. Further, ACS must be ruled out for the diagnosis of EM to be considered.
Noninvasive cardiac imaging such as echocardiography and cardiac MRI may also be used to aid in the diagnosis of EM. Although no specific echocardiographic findings have been definitively associated with EM, endocardial infiltration and fibrosis, apical thrombus formation, wall thickening or motion abnormalities, and reduced ejection fraction are commonly colocalized [15]. Cardiac MRI is better able to demonstrate the extent of endomyocardial involvement in the form of edema, inflammation, and hyper-enhancement on T2-weighted images [16].
To guide specific treatment after diagnosing HES, it is important to identify the HES variant. To diagnose M-HES a cytogenetic abnormality in PDGFRA, PDGFRB, FGFR or PMC1-JAK2 needs to be identified whereas demonstration of TCR clonality or abnormal T-cell marker expression is required to diagnose L-HES [17,18]. If no cytogenetic markers can be identified a diagnosis of idiopathic HES or HES of undetermined significance can be made. When patients present with urgent or life threatening complications, treatment should not be delayed for a complete diagnostic work-up. Initial treatment of severe disease includes high dose corticosteroids with second line agents including imatinib, cyclophosphamide, hydroxyurea, vincristine and mepolizumab [19]. In non-urgent cases, treatment can be deferred until the HES variant is diagnosed.
Imatinib can be used to treat M-HES with nearly universal remission in patients with FLIP1PDGFR fusion genes and mixed results in FLIP1-PDGFR negative patients with L-HES [19-21]. First line treatment of L-HES includes high dose corticosteroids and often requires an additional agent. Imatinib can be used to treat L-HES with response rates between 9-60% depending on the case series. Third line agents for steroid and imatinib resistant M-HES includes hydroxyurea and second or third generation tyrosine kinase inhibitors [19]. Idiopathic HES can be treated with either low or high dose corticosteroids depending on disease severity. If no response to corticosteroids noted, many patients have been shown to respond to hydroxyurea and IFN-a, with a synergistic effect when used in tandem [22, 23].
Patients with chest pain and a troponin leak often undergo invasive investigations, including cardiac catheterizations, to exclude ACS. Frequently, the ischemic evaluation is abandoned prematurely in inpatient settings when initial work up is unrevealing and patients are lost to follow up or present to different inpatient settings with the same unresolved chief complaints – as initially occurred in our case. Within the context of a prior diagnosis of HES and our patient’s clinical presentation, we considered a diagnosis of eosinophilic myocarditis early in the hospital course.
We intentionally omitted an invasive diagnostic cardiac catherization given our patient recently presented with a similar chief complaint at an outside hospital and completed an extensive unrevealing work up. Instead we concentrated our efforts on obtaining all prior outside medical records and promptly initiated treatment with steroids as we suspected EM as the underlying diagnosis. Consequently, we advocate approaching common acute chief complains with a broad differential diagnosis and considering rare diagnoses concurrent to evaluating the most common pathologies in order to provide safe, cost effective, and efficient care for our patients.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
